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ABSTRACT: Probiotics confer health benefits through many
mechanisms including modulation of the gut immune system.
Gut macrophages regulate immune homeostasis, mounting
tolerogenic responses to food and commensal bacteria or immune
inflammatory responses to pathogens.  Local environment and
macrophage subset determine immune response and tolerance,
associated with an M2-like phenotype and inflammatory
activation with an M1-like phenotype.  Subset predominance
will determine immunomodulatory effects of probiotic species
such as Lactobacillus casei strain Shirota (LcS).  The aim of this
study was to investigate differential regulatory effects of LcS on
M1 and M2 macrophage subsets.  PMA or vitamin D
3
differentiated THP-1 human monocytic cells were used to
investigate heat-killed LcS and secreted protein
immunoregulation of M1 and M2 cytokine production,
respectively.  Additionally, regulation of CD14lo M2 and CD14hi
M1 function was investigated. Cytokine expression was measured
by ELISA and NFkB activity by reporter assay.  Both HK-LcS
and SP-LcS augmented IL-1β, suppressed IL-6 and differentially
regulated TNFα and IL-8, dependent on macrophage subset.
HK-LcS and LcS-SP augmented CD14hi M1 TNFα whereas
suppressed CD14lo M2 IL-6 and CD14hi M1 NFkB. In
conclusion, LcS differentially regulates macrophage cytokines and
NFkB activation, is subset-dependent and suggests a cautionary
approach to probiotic treatment of mucosal inflammation.
KEY WORDS: Cytokines, Inflammation, Macrophage,
Monocyte, Probiotics
Corresponding Author: Dr. Andrew Foey, School of Biomedical
and Biological Sciences, University of Plymouth, Drake Circus,
Plymouth PL4 8AA,United Kingdom; E-mail:
andrew.foey@plymouth.ac.uk
INTRODUCTION
The benefits of maintaining a healthy commensal
microbiota has long since been recognised in the probiotic
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field, where supplementation by ingestion of lactic acid
bacteria (LAB) facilitates a balanced microbial environment
beneficial to the host.  More recently, a health benefit of
probiotics in the treatment of allergies has suggested that these
probiotic supplements have a pivotal role to play in modulating
the host’s immune system.  Probiotic investigations have indeed
demonstrated LAB to modulate immune responses elicited
by T, B, NK cells and monocyte/macrophages.  These effects
however, serve to confuse as they often display contradictory
findings from study to study.  This is partly attributable to
immune cell phenotype being studied, its environment and
the strain of probiotic being used.  The Yakult bacteria,
Lactobacillus casei strain Shirota (LcS) has been documented
to be immune activator by inducing high levels of IL-6, TNFα
and IL-12 (Christensen et al., 2002; Matsuguchi et al., 2003).
In contrast, Borruel et al., 2003 found LcS to suppress the
production of TNFα by human intestinal mucosa cells,
preventing inflammatory effects.  LcS has also been
demonstrated to facilitate the development of Th
1
 cells
through the induction of IL-12 (Shida et al., 1998) and to
augment NK cell cytotoxicity (Takeda et al., 2006).  Thus, in
the case of LcS, modulation of immune responses can be both
regulatory/anti-inflammatory and activatory/pro-
inflammatory.  The same ambiguity exists when investigating
another LAB, L. Rhamnosus, which has been shown to
promote development of regulatory DCs (Foligne et al.,
2007a), suppress epithelial cell production of IL-8 (Zhang et
al., 2005), induce IL-12 production (Shida et al., 2006;
Ichikawa et al., 2007) and to increase NK cell numbers (Gill
et al., 2001).  Again, as with LcS, L. Rhamnosus exhibits both
immune-activatory and -regulatory function.  The desired
effect of the probiotic is determined by cell phenotype,
recognition receptor expression and stimuli present in the local
environment.
Commensal bacteria play an important role in gut mucosal
development and function (Rhee et al., 2004). Inappropriate
recognition of conserved commensal pathogen associated
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molecular patterns (PAMPs) by their respective pattern
recognition receptors (PRRs), however, could trigger a
damaging inflammatory immune response.    As a result, it is
vital that recognition of bacterial PAMPs is tightly regulated
allowing the host to tolerate commensal bacteria and, at the
same time, maintaining responsiveness to pathogens.  The
balance between luminal contents such as commensal and
pathogenic bacteria, present in the intestinal microflora, is
vital for mucosal fate: tolerance (immune non-responsiveness)
or immunity (Artis, 2008).  The gastrointestinal tract (GIT)
has developed subtle modifications; integral to this tolerance/
activation decision and prevention of inappropriate immune
responses to commensal bacteria (Schenk and Mueller, 2007),
suppressing TLR, endogenous signal inhibitor and
compartmentalisation of TLR expression as well as up-
regulation of expression and activity upon dangerous insult.
Priming of gut mucosal immune responses requires the
commensal and probiotic bacteria to instruct cells of the
underlying immune tissue.  One of the most pivotal cells in
this immune interaction is the macrophage, residing in the
lamina propria.  Macrophage phenotypes determine the
functional outcome in the gut mucosa.  Indeed, macrophages
generally belong to two distinct subsets- M1 pro-inflammatory
or M2 anti-inflammatory/regulatory macrophages (Mosser
and Edwards, 2008; Stein et al., 1992).  M1 macrophages
play an important role in eradication of invading pathogens
by the production of pro-inflammatory cytokines, hydrolytic
enzymes and reactive oxygen intermediates.  Thus, the
function of M1 macrophages is vital during pathogenic
infection; upon clearance of pathogen however, it is essential
to suppress this function as chronic activation may result in
destructive inflammatory immunopathology.  M2
macrophages, on the other hand, mediate immunoregulatory
function and exhibit an anti-inflammatory effector function
through expression of anti-inflammatory cytokines such as IL-
10 and phagocytic scavenger receptors such as the mannose
receptor (MR).  Due to the differences in effector function of
these subsets, they are both capable of cross-regulating each
other. The relative proportion of these subsets determines
overall immune fate.
Gut mucosal macrophages are central to deciding immune
responsiveness to luminal antigens and bacteria as activatory
or tolerogenic.  This is determined by the cell subsets and
molecules initiated by their local environment.  Macrophages
generally express a wide range of PRRs; intestinal
macrophages, on the other hand, are both functionally and
phenotypically different from blood-derived monocyte/
macrophages. In the healthy gut, tolerant to luminal contents,
intestinal macrophages express MHC II and display a
regulatory/anti-inflammatory phenotype characterised by
phagocytic function, scavenger receptor expression (MR,
CD13, CD36), anti-inflammatory/regulatory cytokine
expression (TGFβ and IL-10), reduced responsiveness to
PAMPs (low or absent expression of CD14 and TLRs) and
fail to express  co-stimulatory molecules (CD80 and CD86);
a phenotype resembling the M2 macrophage subset (Smith
et al., 2001; Smythies, 2005; Platt and Mowat, 2008),
important in immune regulation  and resolution of
inflammation by secreting anti-inflammatory cytokines
(Mahida, 2000).  Pathogenic insult or dysfunctional mucosal
barrier results in inappropriate presentation of luminal
antigens and a breakdown in tolerance leading to a localised
immune activation/inflammation.  Breakdown in tolerance
to commensal bacteria is suggested to contribute to the
pathogenesis of the inflammatory bowel disease, Crohn’s
disease.  In this inflammatory pathology, lamina propria
macrophages display a CD14hi phenotype (Segura et al.,
2002) an increased TLR responsiveness and expression of the
pro-inflammatory cytokines IL-1β, IL-8, IL-12 and TNFα
(Zareie et al., 2001).  This functional phenotype resembles
that of the M1 macrophage subset.  Thus, the macrophage
subset present in the lamina propria is central to determining
immune fate as tolerising or immune activatory/pro-
inflammatory.  Macrophage subset, differentiation status and
resulting effector function of gut mucosal macrophages is
dependent on environmental factors encountered.  As such,
gut mucosal macrophages can be primed towards the M2 anti-
inflammatory/regulatory phenotype in healthy mucosa or
towards a M1 pro-inflammatory phenotype during mucosal
breakdown and immunopathology.  This dichotomy in
macrophage effector phenotype partially explains the
differential regulation of adaptive immune responses between
regulation, cell-mediated immunity or humoral immunity
where M1 cells effect either a Th
1
 or a Th
17
-driven response
and M2 cells effect a Th
2
-driven response (Mills et al., 2000)
or a Treg response.
Probiotic bacteria have been established to modulate
macrophage effector function. LAB have been demonstrated
to modulate macrophage function by either augmenting or
suppressing IL-12 production (Shida et al., 2006; Ichikawa
et al., 2007; Foligne et al., 2007b), suppression of TNFα in
inflamed mucosa (Borruel et al., 2002) and, when
administered at high levels, augment IL-10 (Foligne et al.,
2007b).  These modulatory effects have been described for
whole bacterial cells with subtle differential effects being
described for heat-killed versus live bacteria.  These
observations have lead investigators to study the active
immunomodulatory compartments to probiotic bacteria: cell-
associated or cell-secreted.  The cell wall-derived component
of polysaccharide/PGN complex was demonstrated to suppress
LPS-induced IL-6 production by peripheral blood
mononuclear cells (Matsumoto et al., 2005).  In addition,
when considering the immunomodulatory effects of these
bacteria, secreted metabolites are likely to, and have been
described to, play an important role in modulating the host
immune response.  Indeed, the conditioned medium/secreted
protein extract obtained from the culture of Lactobacillus
plantarum inhibits NFkB activity (Petrof et al., 2009), as such
will have a profound effect on NFkB-dependent immune
functions such as macrophage production of the inflammatory
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cytokines; IL-1β, IL-6, IL-8, MCP-1, IL-12 and TNFα.
The dynamic balance between M1 and M2 macrophages
is suggested to be critical in determining the functional
effector fate of the gut mucosal immune system, immune
activation or induction of tolerance.  Integral to this immune
fate is the activation stimuli available to the macrophage, the
form of the probiotic modulator i.e. whole cell or secreted
functional molecules and the functional phenotype of the
macrophage being investigated.  Thus far, no data exists
focussing on the effects of both probiotic bacterial cells and
secreted proteins on the immunomodulation of functional
behaviour of distinct macrophage subsets, representative of
regulatory/homeostatic gut mucosal macrophages and
infiltrating inflammatory macrophages.  Using a cell-line based
model of high and low CD14 expressing macrophages
resembling mucosal resident homeoststic- and infiltrating
inflammatory macrophages, the aim of this study was to
investigate the immunomodulatory capacity of secreted soluble
proteins and cell-associated LcS on macrophage subset
cytokine phenotype.
MATERIALS and METHODS
Bacterial culture and preparation of heat-killed and secreted
protein extracts
Lactobacillus casei strain Shirota (LcS) was obtained from
commercially available Yakult probiotic drink (Yakult UK).
LcS was cultured aerobically in deMan Rogosa Sharp (MRS)
broth at 37oC.  LcS was cultured in sterile broth culture for
18 hours until stationary phase was achieved.  Bacterial cells
were harvested by centrifugation at 5,000g for 10 minutes,
washed in sterile saline solution and numbers adjusted to give
an OD
600
 reading of 1.2.  This turbidity reading was
determined by cfu counting standards plated on MRS agar
to equate to a count of 1x109 cfu/ml.  LcS was adjusted to a
stock density of 1x1010 cfu/ml and heat killed at 90oC for
120 minutes (HK-LcS) according to the protocol of Young et
al., 2004.  Cell death was confirmed by plating of the bacterial
sample on MRS agar for a minimum of 18 hours.  In addition,
secreted protein was extracted by precipitation of proteins
secreted into growth supernatant by using chilled
trichloroacetic acid (TCA) according to the protocol of
Sanchez et al., 2009.  Protein content was verified by SDS-
PAGE and quantified by calibration to a commercially
available Bradford protein stain.  Secreted protein (LcS-SP)
was adjusted by dilution to a stock concentration of 1mg/ml.
Monocyte and macrophage culture
The human monocytic cell line, THP-1, was obtained from
ECACC and routinely used for this study between passages 7
and 35.  THP-1 cells were maintained in R10 medium
composed of RPMI-1640 medium supplemented with 10%
(v/v) foetal calf serum, 2mM L-glutamine, 100Uml-1 penicillin
and 100µgml -1 streptomycin (Lonza, Wokingham, UK).
THP-1 NFkB reporter cell lines, THP-1Blue (CD14lo) and
THP-1Blue-CD14 (CD14hi) were maintained in R10
medium in the presence of the selection antibiotics, 200µgml -
1 zeocin or 200µgml -1 zeocin and 10µgml -1 blastocidin,
respectively (Autogen Bioclear, Calne, UK).  Cells were plated
out to a final density of 1x105 cells/100µl/well in R10
medium in 96 flat-bottomed well tissue culture plates
(monocyte cultures).  Pro-inflammatory (M1-like) CD14hi
macrophages and anti-inflammatory (M2-like) CD14lo
macrophages were generated by differentiation of these
monocytes in the presence of 25ng/ml PMA for 3 days or
10nM 1,25-(OH)
2
-vitamin D
3
 (Sigma-Aldrich, Poole, UK),
for 7 days, respectively (Daignealt et al., 2010).
Activation of monocyte and macrophage cytokine
production
Monocytes and macrophages were stimulated by the
bacterial pathogen associated molecular pattern (PAMP);
100ng/ml E. coli strain K12 LPS (expressed in enteropathic
GM-negative bacteria and detected by TLR4) and cultured
for 18 hours (determined as optimal time period for expression
of all the cytokines TNFα, IL-1β, IL-6 and IL-8) in a
humidified environment at 37oC, 5% CO
2
. Supernatants
were harvested and stored at -20oC until required for assay by
sandwich ELISA.
Regulatory effect of heat-killed and secreted protein of LcS
To investigate the potential regulation of monocyte and
macrophage cytokine production and NFkB activation, HK-
LcS and LcS-SP were added in culture to final concentrations
of 3x108 bacterial cells/ml and 3µg/ml respectively, as a pre-
treatment for 18 hours prior to stimulation for 18 hours, in a
humidified environment at 37oC, 5% CO
2,
with the bacterial
PAMP, K12-LPS at a concentration of 100ng/ml.  As a control
experiment, to demonstrate a physiologically relevant role for
HK-LcS and LcS-SP, cytotoxicity assays (MTT and trypan blue
exclusion) were carried out on both monocytes and
macrophages, upto 109 and 100µg/ml, respectively.  No
significant reductions in viability were observed for the
concentrations used in this study; viability was routinely >90%.
Cytokine measurement
Monocyte and macrophage production of the pro-
inflammatory cytokines; TNFα, IL-1β, IL-6 and IL-8, were
analysed by sandwich ELISA using commercially available
capture and detection antibodies from R&D Systems UK
Ltd., Abingdon, UK and BD-Pharmingen, Oxford, UK.  Due
to supernatant volume constraints, the CD14hi and CD14lo
NFkB reporter transfectants were assayed for the pro-
inflammatory cytokine, TNFα, and the dual pro- and anti-
inflammatory cytokine, IL-6, in addition to NFkB activity (see
below).  Protocols were followed according to manufacturer’s
instructions and compared to standard curves, between the
range of 7 to 5000pg/ml, using the recognised international
standards available from NIBSC, Potter’s Bar, UK. Colorimetric
development was measured spectrophotometrically by an
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OPTIMax tuneable microplate reader at 450nm and analysed
by Softmax Pro version 2.4.1 software (Molecular Devices
Corp., Sunnyvale, CA, USA).
NFkB activity measurement
NFkB activity was measured by colorimetric reporter
gene assay for secreted embryonic alkaline phosphatase
(SEAP) associated with the stably-transfected reporter gene
cell lines, THP-1Blue (CD14lo) and THP-1Blue-CD14
(CD14hi) (Autogen Bioclear, Calne, UK).  Briefly, at
conclusion of the experiment, fresh supernatant was
harvested and incubated with Quantiblue colorimetric
reagent (Autogen Bioclear, Calne, UK) for 30 minutes at
37oC/5% CO
2
.  Colorimetric development was measured
by an OPTIMax tuneable microplate reader at 620nm and
analysed by Softmax Pro version 2.4.1 software (Molecular
Devices Corp., Sunnyvale, CA, USA).  Colour development
was directly proportional to the reporter gene SEAP
expression and hence NFkB activity.
Statistical analysis
Measure of statistical significance was analysed by a
paired Students’ T test.  Significance was set at p<0.05,
where significant effects of either HK-LcS or LcS-SP
compared to stimulus control were indicated as *p<0.05,
**p<0.01 and ***p<0.001.  NS denotes
not significant.
RESULTS
Heat-killed LcS selectively modulates
LPS-induced monocyte and
macrophage cytokine production
LcS has been demonstrated to
modulate innate immunity;  this
experiment was undertaken to establish
whether heat-ki l led LcS ( in the
absence of any non-specific effects of
lact ic  acid produced) exerted
immunomodulatory effects  on
cytokine expression of THP-1-derived
monocytes and the M1-like and M2-
like subsets of macrophages.  Results
indicated that HK-LcS differentially
regulates  individual  cytokine
expression as well as monocytes, M1
and M2 macrophage subsets.  HK-LcS
augmented K12-LPS-induced
monocyte and M2 TNFα production
from 37± 2pg/ml to 1683±313pg/ml
(p=0.0118) and 148±8pg/ml to
330±10pg/ml (p=0.0012),
respectively.  M1 macrophage
production of TNFα was partially
suppressed by KH-LcS (control
4733±116pg/ml to 3801±750pg/ml, p=0.1264) (Fig.
1a). Expression of IL-1β showed a similar trend to TNFα
expression in the case of both monocytes and M2
macrophages.   HK-LcS augmented LPS-induced
monocyte IL-1β from 30±5pg/ml to 3978±1508pg/ml,
p=0.0455 and M2 IL-1β  from 317±58pg/ml to
844±187pg/ml, p=0.036.  M1 macrophages, however,
also exhibited an augmentation of IL-1β expression by
HK-LcS from 352±57pg/ml to 1612±73pg/ml,
p=0.0034) (Fig 1b).  Monocyte and M2 macrophage IL-
6 production displayed a differential regulation to TNFα
and IL-1β, where HK-LcS suppressed LPS-induced IL-6
from control levels of 188±20pg/ml and 230±92pg/ml
to 24±5pg/ml (p=0.0071) and 92±24pg/ml (p=0.1217)
for monocytes and M2s respectively.  Consistently, M1
macrophages expressed little or no IL-6 at the limits of
detection for the sandwich ELISA (Fig. 1c).  Finally, HK-
LcS differentially regulated monocyte and macrophage
IL-8 production.  Monocyte and M1 LPS-induced IL-8
was augmented from control levels of 63±12pg/ml and
2277±12pg/ml to 3229±149pg/ml,  p=0.0007 and
3888±52pg/ml,  p=0.0002, respectively.   M2 IL-8
production, on the other hand, was suppressed by HK-
LcS from 4270±36pg/ml to 1462±225pg/ml, p=0.0026
(Fig. 1d).
FIGURE 1. Heat-killed LcS selectively modulates LPS-induced monocyte and
macrophage cytokine production. THP-1 monocytes (open bars), M1 (bold) and M2
(shaded) macrophage subsets were stimulated by 100ng/ml E.coli K12 LPS in the presence
or absence of 3x108 cfu/ml heat-killed Lactobacillus casei strain Shirota (+LcS).  M1 and
M2 macrophages were generated by differentiating THP-1 monocytes with either 25ng/
ml PMA for 3 days or 10nM 1,25-(OH)
2
 vitamin D
3
 for 7 days, respectively.  Cytokine
production is expressed as the mean±SD in pg/ml for a) TNFα, b) IL-1β, c) IL-6 and d)
IL-8.  Data displayed is representative of triplicate samples of n=3 replicate experiments.
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LcS secreted protein selectively modulates LPS-induced
monocyte and macrophage production
The data above clearly demonstrates an immunoregulatory
role for HK-LcS.  This regulatory or modulatory role is
understood to be associated with the whole bacteria, in
particular, associated with the cell wall.  Probiotic bacteria can
produce metabolites which are immunomodulatory, such as
short chain fatty acids but also likely to produce
immunomodulatory proteins.  This experiment was
undertaken to establish whether protein secreted from LcS
exerted any immunomodulatory effects on cytokine expression
of monocytes and M1 and M2 macrophage subsets.  Results
indicated that LcS-SP differentially regulates individual
cytokine expression as well as monocytes, M1 and M2
macrophage subsets.  LcS-SP suppressed K12-LPS-induced
monocyte and M1 TNFα production from 38± 6 pg/ml to
19±5 pg/ml (p=0.069) and 4733±116 pg/ml to 481±157
pg/ml (p=0.0011), respectively. M2 macrophage production
of TNFα was not modulated by LcS-SP (control 145±118
pg/ml to 143±33pg/ml, p=0.986) (Fig. 2a).  Expression of
IL-1β showed a consistent augmentation response in
monocytes, M1 and M2 macrophages.  LcS-SP augmented
LPS-induced monocyte IL-1β from 14±2 pg/ml to 501±62
pg/ml, p=0.0055; M1 macrophage IL-1β expression from
146±26pg/ml to 652±65 pg/ml, p=0.0024) and M2 IL-1β
from 129±4pg/ml to 3673±36pg/ml, p<0.0001, (Fig 2b).
Monocyte and M2
macrophage IL-6
production displayed
a differential
regulation to TNFα
and IL-1β, where SP-
LcS suppressed LPS-
induced IL-6 from
control levels of
188±20pg/ml and
230±92pg/ml to
5 ± 2 p g / m l
(p=0.0046) and
2 5 ± 1 5 p g / m l
(p=0.08) for
monocytes and M2s
r e s p e c t i v e l y .
Consistently, M1
m a c r o p h a g e s
expressed little or no
IL-6 at the limits of
detection for the
sandwich ELISA (Fig.
2c).  Finally, LcS-SP
d i f f e r e n t i a l l y
regulated monocyte
and macrophage IL-8
p r o d u c t i o n .
Monocyte LPS-
FIGURE 2. LcS secreted protein selectively modulates LPS-induced monocyte
and macrophage cytokine production. THP-1 monocytes (open bars), M1 (bold)
and M2 (shaded) macrophage subsets were stimulated by 100ng/ml E.coli K12 LPS
in the presence or absence of 3mg/ml Lactobacillus casei strain Shirota secreted
protein (+LcS).  M1 and M2 macrophages were generated by differentiating THP-
1 monocytes with either 25ng/ml PMA for 3 days or 10nM 1,25-(OH)
2
 vitamin D
3
for 7 days, respectively.  Cytokine production is expressed as the mean±SD in pg/ml
for a) TNFα, b) IL-1β, c) IL-6 and d) IL-8.  Data displayed is representative of
triplicate samples of n=3 replicate experiments.
induced IL-8 was augmented from control levels of 63±12
pg/ml to 3229±149 pg/ml, p=0.0007.  M1 IL-8 production
was partially augmented, although not significantly, from
control level of 2277±1134 pg/ml to 3092±773 pg/ml,
p=0.4331.  M2 IL-8 production, on the other hand, was
partially suppressed by LcS-SP from 4270±36 pg/ml to
2468±1080 pg/ml, p=0.1055 (Fig. 2d).
Heat-killed LcS selectively modulates M1 and M2
macrophage subset production of inflammatory mediators:
CD14-dependency
Mucosal macrophage effector phenotype and functions
differ from other tissue macrophages.  They are generally
hyporesponsive CD14lo when present in homeostatic,
tolerogenic mucosa whereas under inf lammatory
condit ions are CD14 hi and express  inf lammatory
mediators.  In an attempt to extrapolate earlier data to
gut mucosal macrophages in inflammatory or tolerogenic
conditions, CD14hi and CD14lo stable transfectants were
driven towards M1 and M2 macrophage subsets and
stimulated by K12-LPS in the presence or absence of LcS.
HK-LcS dramatically augmented LPS-induced TNFα
production by CD14hi M1 cells (from control levels of
1161±148 pg/ml to 4507±367 pg/ml,  p=0.0078)
whereas weakly augmented TNFα production in CD14lo
M1 cells (control 254±13 pg/ml to 397±50 pg/ml,
p=0.0216) (Fig.
3a).   M2
macrophages,  on
the other hand,
produced low levels
of TNFα; however,
CD14lo M2
d i s p l a y e d
suppression by HK-
LcS (control 21±2
pg/ml to 14±1 pg/
ml,  p=0.0067)
whereas CD14hi
M2 TNFα
production was
slightly augmented
(control  11±1pg/
ml to 16±2pg/ml,
p=0.07) (Fig. 3a).
In contrast ,  HK-
LcS fai led to
modulate LPS-
induced IL-6
production by
CD14hi M1 cel ls
(from control levels
of  62±8pg/ml to
7 0 ± 1 8 p g / m l ,
p=0.622) as well as
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CD14lo M1 cells (control 216±5pg/ml to 227±42pg/ml,
p=0.734) (Fig. 3b).  M2 macrophages, on the other hand,
produced higher levels of IL-6 than M1 cells; however,
CD14lo M2, representative of gut homeostatic mucosal
macrophages, displayed a suppression by HK-LcS (control
547±52 pg/ml to 145±26 pg/ml,  p=0.0014)
additionally, CD14 hi M2 IL-6 production was also
suppressed (control 1548±286 pg/ml to 28±6 pg/ml,
p=0.0111) (Fig. 3b).  In addition, any regulation of pro-
inflammatory cytokine expression was expected to be as a
consequence of modulation of NFκB activity, as both
TNFα and IL-6 are regulated by NFκB and exhibit
binding consensus sequences in their respective promoter
regions.  These data are suggestive that LcS regulation of
these pro-inflammatory cytokines is independent of NFkB
activity, when comparing profiles between TNFα, IL-6
and NFkB.  HK-LcS partially suppressed NFkB activity
in both CD14hi and CD14lo M1 cells by 43% and 15%
respectively. HK-LcS suppressed CD14hi M1 LPS-
induced NFkB activity from control  levels  of
0.782±0.0076 to 0.442±0.032 arbitrary units ,
p=0.0017, whereas CD14lo M1 activity was suppressed
from 0.258±0.017 to 0.220±0.0039, p=0.0347.  In
contrast, HK-LcS augmented LPS-induced NFkB activity
in both CD14hi and CD14lo M2 macrophages by 155%
and 46% respectively.  HK-LcS augmented CD14hi M2
LPS-induced NFkB activity from control levels of
0.200±0.0004 to 0.509±0.039 arbitrary units ,
p=0.0051, whereas CD14lo M2 activity was augmented
from 0.220±0.002 to 0.322±0.0061, p=0.0021 (Fig.
3c).
LcS secreted protein selectively modulates M1 and M2
macrophage subset production of inflammatory mediators:
CD14-dependency
LcS-SP dramatically augmented LPS-induced TNFα
production by CD14hi M1 cells (from control levels of
1161±148 pg/ml to 2971±199 pg/ml, p=0.012) whereas
failed to modulate TNFα production in CD14lo M1 cells
(control 254±13 pg/ml to 264±35 pg/ml, p=0.504) (Fig. 4a).
M2 macrophages, on the other hand, produced low levels of
TNFα; however, CD14lo M2 displayed a partial augmentation
by LcS-SP (control 21±2 pg/ml to 30±6 pg/ml, p=0.067)
whereas CD14hi M2 TNFα production failed to be modulated
by LcS-SP (control 11±1pg/ml to 13±2pg/ml, p=0.321) (Fig.
4a).  In contrast, LcS-SP suppressed LPS-induced IL-6
production by CD14hi M1 cells (from control levels of 62±8
pg/ml to 19±9 pg/ml, p=0.0002) whereas LcS-SP failed to
modulate IL-6 production by CD14lo M1 cells (control 216±5
pg/ml to 222±37 pg/ml, p=0.840) (Fig. 4b).  M2
macrophages, on the other hand, produced higher levels of
IL-6 than M1 cells; however, CD14lo M2 displayed a
suppression by LcS-SP (control 547±52pg/ml to 128±24pg/
ml, p=0.0014) additionally, CD14hi M2 IL-6 production was
also suppressed (control 1548±286 pg/ml to 99±39 pg/ml,
p=0.0095) (Fig. 4b).  Again, when comparing profiles between
TNFα, IL-6 and NFkB, these data are suggestive that LcS
regulation of these pro-inflammatory cytokines is independent
of NFkB activity.  LcS-SP partially suppressed NFkB activity in
CD14hi by 40% whilst augmenting CD14lo M1 cells by 21%.
LcS-SP suppressed CD14hi M1 LPS-induced NFkB activity
from control levels of 0.782±0.0076 to 0.465±0.054 arbitrary
units, p=0.0122, whereas CD14lo M1 activity was augmented
from 0.258±0.017 to 0.312±0.005, p=0.0503.  In contrast,
LcS-SP partially augmented LPS-induced NFkB activity in both
CD14hi and CD14lo M2 macrophages by 15% and 47%
respectively.  LcS-SP augmented CD14hi M2 LPS-induced
NFkB activity from control levels of 0.200±0.0004 to
0.229±0.043 arbitrary units, p=0.353, whereas CD14lo M2
activity was augmented from 0.220±0.002 to 0.324±0.025,
p=0.016 (Fig. 4c).
FIGURE 3. Heat-killed LcS selectively modulates M1 and M2
macrophage subset production of inflammatory mediators: CD14-
dependency. CD14hi (bold) and CD14lo (shaded) M1 and M2
macrophages were generated by differentiating CD14hi and CD14lo
THP-1-NFkB reporter monocytes with either 25ng/ml PMA for 3
days or 10nM 1,25-(OH)
2
 vitamin D
3
 for 7 days respectively.  M1
and M2 macrophages were stimulated with 100ng/ml K12-LPS in
the presence (+LcS) or absence of 3x108 cfu/ml heat-killed
Lactobacillus casei strain Shirota.  Cytokine production is expressed
as the mean±SD in pg/ml for a) TNFα and b) IL-6.  NFkB activity (c)
is expressed as the mean±SD in arbitrary absorbance units (A
620nm
).
Data displayed is representative of triplicate samples of n=3 replicate
experiments.
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FIGURE 4. LcS secreted protein selectively modulates M1 and M2
macrophage subset production of inflammatory mediators: CD14-
dependency. CD14hi (bold) and CD14lo (shaded) M1 and M2
macrophages were generated by differentiating CD14hi and CD14lo
THP-1-NFkB reporter monocytes with either 25ng/ml PMA for 3
days or 10nM 1,25-(OH)
2
 vitamin D
3
 for 7 days respectively.  M1 and
M2 macrophages were stimulated with 100ng/ml K12-LPS in the
presence (+LcS) or absence of 3µg/ml secreted protein from Lactobacillus
casei strain Shirota.  Cytokine production is expressed as the mean±SD
in pg/ml for a) TNFα and b) IL-6.  NFkB activity (c) is expressed as the
mean±SD in arbitrary absorbance units (A
620nm
).  Data displayed is
representative of triplicate samples of n=3 replicate experiments.
DISCUSSION
Lactobacillus casei strain Shirota selectively modulates pro-
inflammatory cytokine production by M1 and M2
macrophage subsets.  In addition, the format of LcS, whether
as heat killed whole bacteria or secreted proteins from LcS
bacterial cells, also displays a differential modulation of these
macrophage effector phenotypes.  HK-LcS differentially
modulated cytokine expression that was dependent on degree
of maturation and route of maturation of monocytic/
macrophage cells.  HK-LcS augmented monocyte LPS-
induced TNFα, IL-1β and IL-8 whereas suppressed IL-6
production.  M1 IL-1β and IL-8 production was augmented
by HK-LcS whereas TNFα was suppressed.  When
investigating CD14-dependency, however, TNFα production
was augmented in the pro-inflammatory infiltrating CD14hi
M1 phenotype.  In addition, HK-LcS suppressed NFkB
activation in both CD14hi and CD14lo M1 macrophages.
Neither IL-6 nor TNFα production was suppressed in CD14hi
M1 macrophages. This is suggestive that HK-LcS modulatory
effects on these cytokines are independent of NFkB signalling.
With respect to the anti-inflammatory/regulatory macrophage
subset, M2, TNFα and IL-1β production was augmented
whereas IL-6 and IL-8 were suppressed.  IL-6 production was
suppressed in both CD14hi and CD14lo M2 macrophage
subsets.  Again, NFkB activation did not fully correlate with
HK-LcS modulation of the pro-inflammatory cytokines; it did
however, correlate with TNFα and IL-1β  where an
augmentation observed in TNFα and IL-1β was reproduced
for NFkB activity.  The augmentation of NFkB activity was
observed in both CD14hi and CD14lo M2 macrophages.  LcS-
SP augmented LPS-induced monocyte IL-1β and IL-8
whereas suppressed TNFα and IL-6.  Secreted protein
augmented M1 production of IL-1β and IL-8 and suppressed
M1 TNFα; in contrast, augmented CD14hi production of
TNFα whereas CD14hi M1 NFkB activity was suppressed,
CD14lo M1 cells were hardly modulated by LcS-SP with
respect to both TNFα and NF-kB.  IL-6 expression was
suppressed by secreted protein in CD14hi M1s; no modulation
of IL-6 was observed in CD14lo M1s.  M2 macrophages
exhibit a different modulation profile by secreted protein with
respect to these pro-inflammatory cytokines.  LcS-SP failed to
modulate TNFα, augmented IL-1β whereas suppressed IL-6
and IL-8 production.  Suppression of IL-6 production was
observed for both CD14hi and CD14lo M2 macrophages.
When considering NFkB activity, secreted protein partially
augmented NFkB in both CD14hi and CD14lo M2
macrophages; this does not correlate to either modulation of
TNFα or IL-6 but may play a role in regulation of the IL-1β
response.
From preliminary investigation of the secreted protein
extract, SDS-PAGE analysis showed the presence of 3 protein
bands of varying molecular mass (81KD, 49KD and 26KD,
data not shown).  This extract could vary between probiotic
strains and indeed, proteins secreted during distinct stages of
8   Probiotic modulation of macrophage subset effector responses.
growth.  Future investigations will attempt to identify the
immunomodulatory protein(s) in the secreted protein extract.
More recently, fractionation of a conditioned medium
produced by Lactobacillus rhamnosus GG identified several
protein bands of which, cell wall-associated hydrolase, serpin
B1 and a transcriptional regulator could play a significant role
in modulating host immunity (Sanchez et al., 2009).  In
addition, Lactobacillus fermentum and L. rhamnosus GG have
been shown to secrete immunomodulatory proteins that
regulate signalling pathways that drive pro-inflammatory
cytokine production as well as effector function (Yan et al.,
2007; Frick et al., 2007).  In the case of Lactobacillus casei
strain Shirota, heat-killed LcS exhibited similar
immunomodulatory effects to that of secreted protein,
suggesting that the biological effector function of LcS is shared
between both the bacterial cell-associated fraction and
secreted proteins.  It would be fair to conclude that the Yakult
strain is best used as a bacterial culture rather than substitution
by a secreted, bioactive component.
Cytokines regulated in this study have been stimulated by
LPS of the enteropathic bacterium, E. coli strain K12 which
transduces its signal via TLR4 and induces cytokine expression
through the mitogen activated protein kinase (MAPK) and
NFkB signalling pathways.  It has been established that some
probiotic strains exert their effects through suppression of
these pathways.  Indeed, NFkB has been demonstrated to be
inhibited by certain LAB (Petrof et al., 2004 and 2009).  The
findings of this study however, do not seem to support this
suppressive role on NFkB; HK-LcS only partially suppressed
M1 LPS-induced NFkB activity whereas IL-6 and TNFα
production were not suppressed.  In fact, TNFα produced
by CD14hi M1 macrophages was augmented by HK-LcS;
suggestive of NFkB having a suppressive role in TNFα
production and/or HK-LcS modulates these pro-
inflammatory cytokines in an NFkB-independent manner.
M2 macrophage NFkB, like M1s, did not parallel cytokine
expression; LcS augmented NFkB activity whereas suppressed
IL-6 production.  These data were repeated using LcS-SP.  If
LcS modulation of pro-inflammatory cytokine expression is
independent of NFkB, two alternative pathways present
themselves as integral to these LcS modulatory effects: NOD2
and MAPKs.  NOD2, an intracellular pattern recognition
receptor, has been demonstrated to recognise probiotic
bacteria (Hasegawa et al., 2006).  Specifically, it recognises a
breakdown product of the bacterial cell wall component,
PGN, namely muramyl dipeptide (Girardin et al., 2003).  This
receptor has been demonstrated to have both pro- and anti-
inflammatory function, capable of activation or suppression
of NFkB and MAPK activity.  MAPKs have been shown to
play a role in driving LPS-induced TNFα and IL-1β
production (Foey et al., 1998); modulation of these cytokines
by LcS may well target MAPK activity.  Again, LPS induces
these pro-inflammatory cytokines by activating transcription
factors such as NFkB, cJun and ATF family members; LcS
appears to modulate these responses in an NFkB-independent
manner, then cJun and ATFs, hence JNK (Jun N-terminal
Kinase) and p38 MAPKs may well represent the targets for
modulation by LcS.  Indeed, the probiotic Lactobacillus reuteri
was demonstrated to suppress monocyte and macrophage
TNFα production by inhibition of the MAPK-regulated
transcription factors, cJun and AP-1 (Lin et al., 2008).
Probiotic bacteria are predominantly gram positive,
characterised by external-facing lipoteichoic acid and exposed
PGN which is accessible to host lysosomal enzymes.  PGN has
been described to induce macrophage production of TNFα,
IL-1β and IL-6 (Gupta et al.,1995; Weidemann et al., 1994;
Jin et al., 1998), all of which possess NFkB, AP-1 and CREB
binding sites in their promoters.  Interestingly, PGN activates
AP-1 and CREB/ATF in M2-like vitamin D
3
-differentiated
THP-1 macrophages (Gupta et al., 1999).  CREB/ATF-1
binds to the CRE (c-AMP response element) on these cytokine
promoter regions; cAMP suppresses TNFα expression and,
as such, binding of CREB/ATF-1 to the CRE may serve as a
negative regulatory signal to pro-inflammatory cytokine
production (Foey et al., 2003).  In addition, cAMP has a
positive effect on IL-10 production, thus it is possible that the
immunomodulatory effects of probiotics may be dependent
on the appropriate recognition of PGN, serving to both
directly suppress pro-inflammatory cytokine expression and
indirectly through induction of the anti-inflammatory
cytokine, IL-10.
The cytokine profiles obtained upon stimulation are
different when comparing M1 profiles to that of M2
macrophages.  In addition, they demonstrate a differential
regulation by LcS probiotic products.  The cause of these
differential responses is as a consequence of differential
signalling molecules utilised during macrophage
differentiation and subsequently, activation of these distinct
subsets.  Of particular interest were the preferential expression
of IL-6 by M2 (anti-inflammatory) macrophages and the
suppression of its production upon treatment with both HK-
LcS and LcS-SP.  In addition to its many characterised pro-
inflammatory properties, IL-6 can also exhibit anti-
inflammatory effects via its ability to induce suppressor of
cytokine signalling proteins (SOCS) expression (Xing et al.,
1998; reviewed in Heinrich et al., 2003).  The regulation of
SOCS and their downstream targets, STATs, plays an
important role in macrophage subset differentiation and
determination of effector responses.  SOCS-3 is essential for
function of classical M1 macrophages (Liu et al., 2008) and
suppresses anti-inflammatory effectors that result from IL-10/
IL-6 activation of M2 macrophages, thus controlling
macrophage plasticity; knockout of SOCS3 results in an
alternative M2-like phenotype with increased expression of
arginase, MR, anti-inflammatory cytokines and SOCS-1.
Thus, there is a reciprocal relationship between SOCS-3 and
SOCS-1 regulation of STAT-3 and STAT-1-dependent genes
expressed by the M2 and M1 subsets respectively.  In addition
to IL-6, another cytokine which is generally considered pro-
inflammatory, IL-1β, also exhibits anti-inflammatory
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properties; its response is probably mediated by its ability to
induce IL-10 expression (Foey et al., 1998).  LcS treatment of
M2 macrophages augmented IL-1β production; these M2
cells generally express IL-10 that also signals through STAT-
3. Conversely, pro-inflammatory TNFα, predominantly
produced by the pro-inflammatory M1 macrophage
phenotype, not only can induce IL-6 but can inhibit it’s action
via the induction of SOCS-3 expression (Bode et al., 1999).
SOCS-3 induction will again affect macrophage plasticity by
inhibiting STAT-3, hence reversal of M2 macrophages to a
pro-inflammatory, M1 effector phenotype.  Thus, probiotic
modulation of cytokine effector responses mediated by SOCS/
STAT interactions would have a dramatic effect on
macrophage plasticity, hence effector phenotype.
The inflammatory cytokines investigated in this study
(TNFα, IL-1β, IL-6 and IL-8) have all been described to be
dependent on NF-kB activity (Bondeson et al., 1999).  The
fact that the LcS cytokine modulation profile did not always
follow the NFkB activation profile suggests that there was a
varying degree of NFkB-dependency, determined by CD14
expression and macrophage subset differentiation.  In
addition, although not directly modulating cytokine
expression, NFkB may play an indirect role in cytokine
expression through controlling macrophage polarisation/
differentiation.  The endogenous upstream activator of NFkB,
IKKβ has been described to maintain the M2 macrophage
phenotype, whereas deletion of IKKβ facilitated reversion to
an M1 phenotype (Hagemann et al., 2008).  The alternative
NFkB p50 subset homodimer also controls macrophage
plasticity; inhibition of p50 NFkB resulted in M2
macrophages reverting to an M1 phenotype through the
restoration of STAT-1 activity (Hagemann et al., 2008; Porta
et al., 2009).  Taken together, there is a SOCS/STAT/NFkB/
MAPK signalling axis integral to macrophage plasticity and
cytokine effector phenotype.  Modulation of macrophage-
driven immune responses by probiotic bacteria will be
dependent on regulation of this axis; the same probiotic may
induce both immune activatory and immune regulatory
responses, dependent on the macrophage phenotype being
exhibited by the local gut mucosal macrophages responding
to these bacteria.
Finally, macrophage subset expression of CD14 has a role
to play in cytokine expression, NFkB activation and regulation
by probiotic bacteria.  HK-LcS and LcS-SP greatly augmented
TNFα production by CD14hi M1 macrophages that exhibit
a phenotype similar to infiltrating pro-inflammatory
macrophages in the inflamed gut mucosa.  No such dramatic
up-regulation was observed either in CD14lo M1 or M2
macrophage subsets.  This observation alone is suggestive of a
cautionary approach to the use of probiotics in the case of
patients with inflammatory disease that display an increased
proportion of CD14hi M1-like macrophages infiltrating the
gut mucosa.  The use of such probiotics should only be
considered once the macrophage effector phenotype has been
characterised for the inflammatory pathology.  Both HK-LcS
and LcS-SP displayed little effect on both CD14hi and CD14lo
M1 production of IL-6.  M2 macrophages however, were
dramatically regulated: LcS suppressed LPS-induced M2
production of IL-6, independent of CD14 expression.  As
discussed, IL-6 is both pro- and anti-inflammatory; its anti-
inflammatory effects being mediated through STAT-3, a
prominent transcription factor in regulating M2 macrophages.
It is possible that LcS not only suppresses pro-inflammatory
responses but also anti-inflammatory responses. The resulting
effector outcome, with regards mucosal inflammation will then
be determined by the net strength of regulatory/inflammatory
mediators and their receptor-mediated responses.  The most
significant result obtained with respect to NFkB modulation
was observed for both CD14hi M1 and CD14hi M2
macrophages when modulated by HK-LcS: suppressing M1
whereas enhanced M2 NFkB activity; this activity however,
did not correlate with either TNFα or IL-6 production.  This
result is suggestive that these CD14-dependent observations
for NF-kB activation were independent of the resulting LcS
modulation of cytokine production and that other signalling
pathways are important in LcS modulation of macrophage
cytokine production.
In conclusion, signals induced by bacterial cell-
associated and secreted protein products of the probiotic
bacterium, Lactobacillus casei strain Shirota differentially
regulate macrophage production of the pro-inflammatory
cytokines TNFα, IL-1β, IL-6 and IL-8 as well as modulating
the activity of the pro-/anti-inflammatory transcription factor,
NFkB.  Modulation of these cytokine profiles is determined
by macrophage effector phenotype and the expression levels
of CD14.  The modulatory results for HK-LcS did not fully
parallel those of LcS-SP, thus the cell-derived component is
essential when considering design of probiotics to be used as
a prophylactic in healthy individuals or for the treatment of
pathological conditions.  The future development of probiotics
will take into consideration strain-specific effects and will be
tailored to the desired effect on both the microbial population
of the gut and the host’s immune system.
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